ATE89742T1 - Stabilisierter attenuierter lebender impfstoff und seine herstellung. - Google Patents

Stabilisierter attenuierter lebender impfstoff und seine herstellung.

Info

Publication number
ATE89742T1
ATE89742T1 AT88305166T AT88305166T ATE89742T1 AT E89742 T1 ATE89742 T1 AT E89742T1 AT 88305166 T AT88305166 T AT 88305166T AT 88305166 T AT88305166 T AT 88305166T AT E89742 T1 ATE89742 T1 AT E89742T1
Authority
AT
Austria
Prior art keywords
stabilized
production
live vaccine
attached live
attached
Prior art date
Application number
AT88305166T
Other languages
English (en)
Inventor
Satoshi Makino
Keiko Sasaki
Masaharu Nakagawa
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of ATE89742T1 publication Critical patent/ATE89742T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AT88305166T 1987-06-08 1988-06-07 Stabilisierter attenuierter lebender impfstoff und seine herstellung. ATE89742T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62142465A JPS63307827A (ja) 1987-06-08 1987-06-08 安定化された生ウイルスワクチンおよびその製造法
EP88305166A EP0295043B1 (de) 1987-06-08 1988-06-07 Stabilisierter attenuierter lebender Impfstoff und seine Herstellung

Publications (1)

Publication Number Publication Date
ATE89742T1 true ATE89742T1 (de) 1993-06-15

Family

ID=15315947

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88305166T ATE89742T1 (de) 1987-06-08 1988-06-07 Stabilisierter attenuierter lebender impfstoff und seine herstellung.

Country Status (8)

Country Link
US (1) US4985244A (de)
EP (1) EP0295043B1 (de)
JP (1) JPS63307827A (de)
KR (1) KR910009346B1 (de)
AT (1) ATE89742T1 (de)
BE (1) BE1001533A3 (de)
DE (1) DE3881281T2 (de)
ES (1) ES2041796T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3045581B2 (ja) * 1991-10-14 2000-05-29 社団法人北里研究所 麻疹ワクチンウイルス株同定方法
CA2075521C (en) * 1992-05-05 1995-11-28 Kuniaki Koyama Stabilized live vaccine
AU687497B2 (en) * 1993-12-21 1998-02-26 Merck & Co., Inc. Thermostable varicella zoster virus
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
AU725231B2 (en) * 1996-12-20 2000-10-12 Merck & Co., Inc. Stabilisers for lyophilised vaccines
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
GB9808922D0 (en) 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
US6586411B1 (en) 2000-08-16 2003-07-01 Mayo Foundation For Medical Education And Research System for monitoring the location of transgenes
US6896881B1 (en) 1999-09-24 2005-05-24 Mayo Foundation For Medical Education And Research Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
MXPA02004666A (es) 1999-11-12 2003-06-24 Fibrogen Inc Gelatinas recombinantes.
GB9930882D0 (en) * 1999-12-30 2000-02-23 Nps Allelix Corp GLP-2 formulations
RU2158134C1 (ru) * 2000-03-10 2000-10-27 Унитарное Государственное "Московское Предприятие По Производству Бактерийных Препаратов" Способ получения ассоциированной паротитно-коревой вакцины
US7118740B1 (en) 2000-09-22 2006-10-10 Mayo Foundation For Medical Education And Research Method for limiting the growth of cancer cells using an attenuated measles virus
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
US9951117B2 (en) 2010-09-02 2018-04-24 Mayo Foundation For Medical Education And Research Vesicular stomatitis viruses
JP5944901B2 (ja) 2010-09-02 2016-07-05 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 水疱性口内炎ウイルス
US20150224181A1 (en) 2012-09-14 2015-08-13 The United States Of America As Represented By The Secretary Department Of Health And Human Se Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
CN103599530B (zh) * 2013-10-30 2015-04-22 天津津斯特疫苗有限责任公司 一种用无血清培养基制备风疹减毒活疫苗的方法
KR20170028992A (ko) * 2014-07-18 2017-03-14 엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드 열안정성 동결 건조된 로타바이러스 백신 제형 및 이의 제조 방법
CA2971201A1 (en) * 2014-12-18 2016-06-23 Amgen Inc. Stable frozen herpes simplex virus formulation
AU2016302237B2 (en) 2015-08-03 2022-08-04 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424031A1 (fr) * 1978-04-24 1979-11-23 Merck & Co Inc Stabilisateur de vaccin
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
DE3601922A1 (de) * 1986-01-23 1987-07-30 Behringwerke Ag Stabilisiertes virus-antigen, verfahren zu seiner herstellung und seine verwendung

Also Published As

Publication number Publication date
JPS63307827A (ja) 1988-12-15
DE3881281T2 (de) 1993-09-09
KR890000107A (ko) 1989-03-11
US4985244A (en) 1991-01-15
EP0295043A2 (de) 1988-12-14
BE1001533A3 (fr) 1989-11-21
ES2041796T3 (es) 1993-12-01
KR910009346B1 (ko) 1991-11-12
DE3881281D1 (de) 1993-07-01
EP0295043B1 (de) 1993-05-26
EP0295043A3 (en) 1989-07-26

Similar Documents

Publication Publication Date Title
ATE89742T1 (de) Stabilisierter attenuierter lebender impfstoff und seine herstellung.
DK0529584T3 (da) Viralt agens forbundet med "Mystery Swine Disease"
DK0839525T3 (da) Præparat med forlænget frigivelse
NO2008010I1 (no) Kombinasjon av efavirenz, emtricitabin og tenofovirdisoproks: 1 eller salter derav
FI873672A0 (fi) Kompositioner innehaollande l-3,4-dihydroxifenylalanin.
FI97777B (fi) Menetelmä silmätipoiksi tarkoitetun koostumuksen valmistamiseksi
DE3682208D1 (de) Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung.
DE58900183D1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
FI903826A0 (fi) Ny arginindeiminase, dess framstaellningsfoerfarande och ett anti-cancermedel innehaollande denna enzym som effectiv ingredient.
DE69528074D1 (de) Chitosan induzierte verstärkung
DE69015305D1 (de) Stabile immunogene Zusammensetzung.
DK0533294T3 (da) Kyllingeanæmiagensvaccine.
IT1239029B (it) Processo per la preparazione dell'acido 3-(l-piroglutamil)-l- tiazolidin-4-carbossilico e suoi derivati.
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
ATE150086T1 (de) Cdns-sequenz und detektion des hepatitis c-virus
NO176163C (no) Fremgangsmåte for fremstilling av en levende herpesvirusvaksine
DE68920345D1 (de) Lebendes Kombinationsvakzin.
ES2067302T3 (es) Suspension a base de acido alginico.
ATE138074T1 (de) Disulfat von ws-7622a, verfahren zur herstellung und benutzung
ATE53205T1 (de) Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung.
IT1223171B (it) Procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b. bronchiseptica e vaccino ar vivo attenuato cosi' ottenuto
KR920021163A (ko) 비-자극성 백신 조성물
HUP9603364A2 (hu) Ipriflavont tartalmazó csonthiány pótlására szolgáló gyógyászati készítmény és eljárás előállítására
DE59304579D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-5-hydroxyoxindolen und deren Etherderivaten
IT9003363A0 (it) Metodo per la fabbricazione di calzature,in particolare con il fondo acuscino d'aria,e calzatura ottenuta con tale metodo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee